Stories of Long COVID have emerged from around the world and are becoming increasingly common, including in patients who weren’t admitted to hospital and didn’t experience serious symptoms. As cases grow, experts are warning the consequences of Long COVID could have a serious impact on the overall health and wellbeing of the global population. Headaches, heart damage ...
OHMX.bio, a provider of cutting-edge “omics” solutions, and Fujirebio Europe announced today that they have been awarded a 720K EURO research grant from Flanders Innovation & Entrepreneurship (VLAIO) to develop a clinical in vitro diagnostics (IVD) platform incorporating third generation sequencing (TGS) technologies. The project, called IVD-seq, will initially focus on ...
Pioneered by a team of physicians and anthropologists, the 16-year-long study analysed the body temperatures of indigenous Tsimane people living in the Bolivia’s Amazon region. Over the study period the team noticed a significant drop in the average body temperatures of healthy Tsimane adults, with the average now 36.5 degrees Celsius. "In less than two decades we're ...
“When complete, our DNA-based vaccine will be administered non-invasively as a nasal spray that delivers nanomedicine engineered to immunize and decrease COVID-19 infections,” says Roderick Slavcev, a professor in the School of Pharmacy at the University of Waterloo. “This research combines the expertise of many and leverages existing technology developed by my team, whi...
As an immediate action to contain the spread of the COVID-19 pandemic, laboratories are ramping up testing for the SARS-CoV-2 virus. To date, a number of test variants have emerged. Even though the most common remains throat swabs, some national bodies are also conducting antibody tests that require blood to be drawn and analyzed. Irrespective of the type of test, the ac...
The company said its Fast Track Diagnostics (FTD) SARS-COV-2 Assay is already being shipped in Europe for research use only (RUO) to expedite availability while it continues to pursue Emergency Use Assessment and Listing (EUAL) from the World Health Organization (WHO) for clinical use. In addition, the company is in talks with FDA to release the test under Emergency U...
Incorporating artificial intelligence, image processing, and molecular virology, researchers from a trio of british universities have developed a device that can detect the virus in 30 minutes using a smartphone app. The device would allow those who are self-isolating to test themselves, while health care workers could test patients, and themselves, to slow the pandemic’...
The coronavirus SARS-CoV-2 is posing major challenges for healthcare systems and medical institutions worldwide. An ability to rapidly diagnose the virus is of invaluable help in curbing its exponential spread in many countries. Bosch’s new, fully automated rapid test for COVID-19 can help medical facilities such as doctors’ offices, hospitals, laboratories, and health c...
A lack of testing capacity is one of the key hurdles currently facing the US in diagnosing and tracking cases of COVID-19. But at-home test kits for less urgent cases could soon help ease the burden as well as increase safety for health care workers and members of the public. However, companies currently making such home-based collection kits already seem to be runnin...
The authorization was made Friday and tests will begin shipping next week, according to a statement from California-based Cepheid, the company manufacturing the tests. "During this time of increased demand for hospital services, Clinicians urgently need an on-demand diagnostic test for real-time management of patients being evaluated for admission to health-care facil...
The Georgia Esoteric and Molecular Laboratory at the Medical College of Georgia Department of Pathology has developed a novel, accurate coronavirus test that can tell patients if they are infected within about two hours instead of waiting typically days to hear from remote testing facilities. "We want patients and physicians in our community to have timely access to i...
One major challenge in the US response to the novel coronavirus pandemic has been the availability of test kits and the reagents required to use those kits. Public health authorities say accurate and widespread testing is critical in identifying COVID-19 hotspots and how it is spreading, as well as ensuring infected patients are treated quickly. But, as recently as la...
As of Friday (March 20), 86 clinical trials of COVID-19 treatments or vaccines that are either ongoing or recruiting patients. New ones are being added every day, as the case count in the U.S. (and globally) skyrockets. The drugs being tested range from repurposed flu treatments to failed ebola drugs, to malaria treatments that were first developed decades ago. Here, we ...
Gent, Belgium, Cambridge, Mass., USA, and Rostock and Berlin, Germany – November 9, 2020: Fujirebio Europe and Centogene N.V. (Nasdaq: CNTG) announced today to have entered a partnership to leverage LUMIPULSE® G technology for large-scale COVID-19 antigen testing with further deployment in German airports. As part of the agreement, Fujirebio will provide a steady supp...
What’s more, RNA-targeting CRISPR systems are advancing on important applications for which they are uniquely well suited. For example, they can silence gene expression at the transcriptional level, which is advantageous if the corresponding targets at the genomic level are hard to access. Also, RNA-targeting CRISPR systems can be effective in targeting RNA viruses such ...
Malaysia's Medical Innovation Ventures (Mediven®) achieved 100% concordance for GenoAmp®, its COVID-19 PCR test kit in an international third party evaluation study External Quality Assessment (EQA) / Proficiency Testing (PT) from the UK. The study is participated by many international brands from South Korea, Spain, France, China, Germany, USA, Turkey, Australia and ...
In December 2019, several cases of atypical pneumonia were reported in the city of Wuhan in China. Laboratory tests confirmed that the causative pathogen was a novel coronavirus, provisionally named 2019-nCoV and now called SARS-CoV-2. SARS-CoV-2 causes the disease officially designated as COVID-19 by the World Health Organization (WHO). As of February 27, 2020, the WHO ...
After months of rumors, Thermo Fisher Scientific is finally acquiring Qiagen for $11.5 billion. The deal calls for Waltham, MA-based Thermo Fisher Scientific to spend about $43.6 per share for Qiagen. The move also comes after Qiagen terminated talks for a merger on Christmas Eve. The offer price represents a premium of about 23% to the closing price of Venlo, Netherl...
"To really deliver on the promise of precision oncology, providers need to access, interpret, and apply this genomic information where and when clinical decisions are made: the EHR," said Dr. Mia Levy, the Sheba Foundation Director of the Rush University Cancer Center and a national leader in biomedical informatics. "This new technology makes point-of-care insights and i...
Many so-called diseases of civilization or lifestyle diseases such as cardiovascular diseases and obesity seem to increase in frequency. Even so, we all want to stay fit and healthy for as long as possible. To motivate people to exercise more and to stay healthy, eGym relies on a mixture of automated training equipment, educated professionals and digital solutions. At...
The assets constitute the entire operations of Memorial Hermann Diagnostic Laboratories (MHDL), the outreach laboratory division of Memorial Hermann. Quest will also buy about 30 MHDL patient service centres and nearly 60 in-office laboratory service sites. Via a multi-year agreement, Quest will offer professional laboratory management services for all of Memorial ...
The test can detect the presence of SARS-CoV-2, antibodies against the virus (potentially indicating a level of immunity), and inflammatory markers that could indicate the severity of COVID-19. Using blood or saliva, the test can provide a result in as little as 10 minutes. The researchers hope that it could soon be used by people at home to assess their COVID-19 status....
Mapping this part, called the spike protein, is an essential step so researchers around the world can develop vaccines and antiviral drugs to combat the virus. The paper is publishing Wednesday, February 19, 2020, in the journal Science. The scientific team is also working on a related viable vaccine candidate stemming from the research. Jason McLellan, associate p...
Some have questioned the accuracy of the statistics released by the Chinese government regarding the reported number of cases and deaths due to the outbreak. Now there are concerns about the accuracy of the laboratory tests used to confirm diagnoses. Reports suggest some people test negative up to six times even though they are infected with the virus, according to th...
Viruses can remain infectious on surfaces like metal, glass, or plastic for hours to days. Consequently, cleaning and disinfecting a microscope regularly is important to help keep lab technicians and research staff safe and healthy. Please read on for best practices to keep the microscope and optical system clean and sterilized. Cleaning and disinfecting a lab micr...
In addition to being uncomfortable, the current gold standard for COVID-19 testing requires RT-PCR, a time-consuming laboratory procedure. Because of backlogs, obtaining a result can take several days. To reduce transmission and mortality rates, healthcare systems need quick, inexpensive and easy-to-use tests. Hossam Haick, Hu Liu, Yueyin Pan and colleagues wanted to dev...
EKF Diagnostics announces that the novel viral transport media PrimeStore® MTM (Molecular Transport Medium) has been successfully evaluated for effective SARS-CoV-2 inactivation in a new study published by Public Health England (PHE) [1]. To work safely with live SARS-CoV-2 samples requires the use of high-containment laboratories. However, after inactivation SARS-CoV-2 ...
Russian vaccine Between June 18 and Aug. 3, 2020, Russian scientists enrolled 76 healthy adults aged 18 to 60 in two Phase I/2 trials. Both studies assessed the effectiveness and safety of the vaccine, which comprises two components—a recombinant adenovirus type 26 (rAd26) vector and a recombinant adenovirus type 5 (rAd5) vector, both carrying the gene for SARS-CoV-2 ...
Researchers at the U.S. Army CCDC Army Research Laboratory (Aberdeen Proving Ground, MD, USA), the University of Pittsburgh Medical Center (UPMC, PA, USA), and other institutions conducted tests of a commercial passive protective enclosure (also known as an intubation box) to evaluate and compare it to a modified intubation biocontainment unit (IBU) with an active air fi...
In addition, there are gaps in the understanding of the molecular mechanisms of these diseases. All of these converging factors make disease progression difficult to predict. A new study published today illustrates that artificial intelligence (AI) analysis of blood samples can be used to predict disease progression. Researchers at The Neuro (Montreal Neurological Ins...
Optimised protocols for popular instruments manufactured by Dynex, Stratec, Awareness, and Delta Biologicals are now available, as well as for Erba's own analysers including the ELAN 30s microstrip processor. Such protocols will help meet or exceed manual performance characteristics and start reporting clinical results faster and with more confidence. Nikhil Vazirani,...
A team of international researchers, which includes a Saint Louis University Madrid anthropologist, dug deep to find some of the oldest African DNA on record, in a new study published in Nature. Africa is the homeland of our species and harbors greater human genetic diversity than any other part of the planet. Studies of ancient DNA from African archaeological sites c...
Acute myeloid leukemia is the most common type of leukemia in adults. It is characterized by the pathological expansion of immature cells (myeloblasts) that invade the bone marrow and expand into the blood, affecting the production of the rest of the healthy cells. Although patients usually respond well to chemotherapy-based treatments, a large proportion of them eventua...
Highlights: Reanalysis of patient samples from three US labs shows most tests didn't adequately analyze more than a quarter of genes. Chance of detecting a disorder varied widely depending on which genes the lab completely analyzed in a given sample. DALLAS, TX — Children who undergo expansive genetic sequencing may not be getting the thorough DNA analysis their pa...
The finding could lead to the development of new strategies against vancomycin-resistant enterococci (VRE), which causes thousands of deaths in the United States alone. “We have uncovered the ‘Achilles’ heel’ of an important hospital-associated and multidrug-resistant pathogen,” said Cesar Arias, MD, PhD, a professor at McGovern Medical School at UTHealth and the Herb...
Gent, Belgium - September 4, 2020: Fujirebio Europe and ADx NeuroSciences announced today that they have concluded an agreement related to the development and commercialization of new assays in the field of neurodegeneration. Included in the scope of the agreement is the supply of antibodies as well as the transfer of know-how and/or prototype assays from ADx to Fujir...
